Japan, Oct. 30 -- JANSSEN BIOTECH INC has got intellectual property rights for 'BISPECIFIC EGFR/C-MET ANTIBODIES.' Other related details are as follows:
Application Number: JP,2023-203256
Category (FI): C07K16/28,A61P35/04,A61P35/00,A61K39/395@T,C12N15/62@Z,C12N15/13,C07K16/46
Stage: Grant (IP right document published.)
Filing Date: Nov. 30, 2023
Publication Date: Feb. 28, 2024
The original document can be viewed at: https://www.j-platpat.inpit.go.jp/p0100
Disclaimer: Curated by HT Syndication....